New 'Living Drug' trial offers hope for patients with aggressive lymphoma

NCT ID NCT04989803

Recruiting now Disease control Sponsor: Kite, A Gilead Company Source: ClinicalTrials.gov ↗

Summary

This study is testing two new personalized cell therapies, KITE-363 and KITE-753, for people with B-cell lymphoma that has come back or hasn't responded to standard treatments. The main goals are to find a safe dose and see how well these therapies can shrink tumors. Researchers will enroll about 247 participants to monitor their health and the cancer's response for up to 15 years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED AND/OR REFRACTORY B-CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Academisch Medisch Centrum
RECRUITING

Amsterdam, 1105 AZ, Netherlands
Banner MD Anderson Cancer Center
RECRUITING

Gilbert, Arizona, 85234, United States
Columbia University Irving Medical Center
RECRUITING

New York, New York, 10032, United States
Hackensack University Medical Center
RECRUITING

Hackensack, New Jersey, 07601, United States
King's College Hospital
RECRUITING

London, SE5 9RS, United Kingdom
Northside Hospital
RECRUITING

Atlanta, Georgia, 30342, United States
Royal North Shore Hospital
RECRUITING

St Leonards, New South Wales, 2065, Australia
Stanford Cancer Institute
RECRUITING

Stanford, California, 94305, United States
The Ohio State University Wexner Medical Center - James Cancer Hospital
RECRUITING

Columbus, Ohio, 43210, United States
The University of Texas, MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
Universitatsklinikum Wurzburg
RECRUITING

Würzburg, 97080, Germany
University of MD, Greenebaum Comprehensive Cancer Center
RECRUITING

Baltimore, Maryland, 21201, United States
University of Rochester Medical Center
RECRUITING

Rochester, New York, 14642, United States
Virginia Oncology Associates
RECRUITING

Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.

RELAPSED AND/OR REFRACTORY B-CELL LYMPHOMA